Number of Shares
3.67 Mil
Current Holdings Value*
$234.46 Mil
% of Portfolio
5.12%
Total Estimate Gain
$153.20 Mil
% of Total Estimate Gain
92.50%

SNYDER CAPITAL MANAGEMENT L P's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, SNYDER CAPITAL MANAGEMENT L P held 3.67 Mil shares of Halozyme Therapeutics Inc(HALO), totaling $234.46 Mil. This investment constitutes 5.12% of their stock portfolio, and SNYDER CAPITAL MANAGEMENT L P now holds 2.98% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2018Q2. And since then SNYDER CAPITAL MANAGEMENT L P has made 16 purchases of HALO, at an average price of $27.54, for a total of 6.01 Mil shares. In addition, there have been 12 sales at an average price of $44.00 for 2.34 Mil shares. Based on historical transaction data and HALO's current price of $58.77, SNYDER CAPITAL MANAGEMENT L P's estimated gain on his HALO holdings is $153.20 Mil, reflecting a 92.50% gain to date.

SNYDER CAPITAL MANAGEMENT L P HALO ($58.77) Holding Chart

SNYDER CAPITAL MANAGEMENT L P HALO ($58.77) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1